“Evaluation of chronic obstructive pulmonary disease (COPD) and reduced ejection fraction heart failure (HFrEF) discharge medication prescribing: Is drug therapy concordant with national guidelines associated with a reduction in 30-day readmissions?” [Respir. Med. 119 (October 2016) 135–140]

“Evaluation of chronic obstructive pulmonary disease (COPD) and reduced ejection fraction heart failure (HFrEF) discharge medication prescribing: Is drug therapy concordant with national guidelines associated with a reduction in 30-day readmissions?” [Respir. Med. 119 (October 2016) 135–140]

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Respiratory medicine 2017-02, Vol.123, p.150-150
Hauptverfasser: Richardson, Amy, Tolley, Elizabeth, Hartmann, Jonathan, Reedus, Jasmine, Bowlin, Brandi, Finch, Christopher, Sands, Christopher W, Self, Timothy
Format: Artikel
Sprache:eng
Schlagworte:
Pulmonary/Respiratory
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 150
container_issue
container_start_page 150
container_title Respiratory medicine
container_volume 123
creator Richardson, Amy
Tolley, Elizabeth
Hartmann, Jonathan
Reedus, Jasmine
Bowlin, Brandi
Finch, Christopher
Sands, Christopher W
Self, Timothy
description
doi_str_mv 10.1016/j.rmed.2016.11.013
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1846027385</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0954611116303080</els_id><sourcerecordid>4311598401</sourcerecordid><originalsourceid>FETCH-LOGICAL-c413t-835547ac9719517eda8006c35c878e135077f885d5fd44d8d99e068afa994a053</originalsourceid><addsrcrecordid>eNp9ks2O0zAUhQMCMWXgBVigK7FpkVLsOL8IgVBpmZEGDeJnhZDl2jetO2kc7KSou74DW3i5PglOOyOkWbDylX3O8fX1FwRPKBlTQtMXq7FdoxpHvh5TOiaU3Q0GNGFRyEga3wsGpEjiMKWUngQPnVsRQoo4Jg-CkygraBrn0eDO8_3u93Qjqk602tRgSpBLa2otwcxdazvZ6g1C01VrUwu7BaUdCocwnFx-fDcCUSuwqDqJCnCF8hBSWnEslihsC6XQVWe95Wxmp7NRHyGXwi4QfPdaHi9uLDpp9VzXi5dw7kDZbgHtEq1otiBNLY1Vom7hp26XUB88ooJFpxVWukYHwjkjtWh9IweNOPZ1CNc1MBIqsfV7Qq21c37Xvdnv_sC3T-gabcfwwU8SKC1geClbM0cL_VxHQFmy3_2iMfn-KLhfisrh4-v1NPg6m36ZnIUXl-_PJ28vQhlT1oY5S5I4E7LIaJHQDJXICUklS2Se5ejjSJaVeZ6opFRxrHJVFEjSXJSiKGJBEnYaDI-5jTU_OnQt9x1LrCpRo-kcp3mckihjeS99dku6Mp31k-lVKUtSlqbUq6KjSlrjnMWSN1av_W9ySnhPEl_xniTev5hTyj1J3vT0Orqb92c3lht0vODVUYB-FhuNljupsfYkaOtB4Mro_-e_vmWX_iM9DtUVbtH9ewd3ESf8c89yjzJNGWEkJ-wvO83yjQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1863563661</pqid></control><display><type>article</type><title>“Evaluation of chronic obstructive pulmonary disease (COPD) and reduced ejection fraction heart failure (HFrEF) discharge medication prescribing: Is drug therapy concordant with national guidelines associated with a reduction in 30-day readmissions?” [Respir. Med. 119 (October 2016) 135–140]</title><source>Elsevier ScienceDirect Journals Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Richardson, Amy ; Tolley, Elizabeth ; Hartmann, Jonathan ; Reedus, Jasmine ; Bowlin, Brandi ; Finch, Christopher ; Sands, Christopher W ; Self, Timothy</creator><creatorcontrib>Richardson, Amy ; Tolley, Elizabeth ; Hartmann, Jonathan ; Reedus, Jasmine ; Bowlin, Brandi ; Finch, Christopher ; Sands, Christopher W ; Self, Timothy</creatorcontrib><identifier>ISSN: 0954-6111</identifier><identifier>EISSN: 1532-3064</identifier><identifier>DOI: 10.1016/j.rmed.2016.11.013</identifier><identifier>PMID: 27916482</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Pulmonary/Respiratory</subject><ispartof>Respiratory medicine, 2017-02, Vol.123, p.150-150</ispartof><rights>Elsevier Ltd</rights><rights>2016 Elsevier Ltd</rights><rights>Copyright Elsevier Limited Feb 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c413t-835547ac9719517eda8006c35c878e135077f885d5fd44d8d99e068afa994a053</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.rmed.2016.11.013$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27916482$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Richardson, Amy</creatorcontrib><creatorcontrib>Tolley, Elizabeth</creatorcontrib><creatorcontrib>Hartmann, Jonathan</creatorcontrib><creatorcontrib>Reedus, Jasmine</creatorcontrib><creatorcontrib>Bowlin, Brandi</creatorcontrib><creatorcontrib>Finch, Christopher</creatorcontrib><creatorcontrib>Sands, Christopher W</creatorcontrib><creatorcontrib>Self, Timothy</creatorcontrib><title>“Evaluation of chronic obstructive pulmonary disease (COPD) and reduced ejection fraction heart failure (HFrEF) discharge medication prescribing: Is drug therapy concordant with national guidelines associated with a reduction in 30-day readmissions?” [Respir. Med. 119 (October 2016) 135–140]</title><title>Respiratory medicine</title><addtitle>Respir Med</addtitle><subject>Pulmonary/Respiratory</subject><issn>0954-6111</issn><issn>1532-3064</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9ks2O0zAUhQMCMWXgBVigK7FpkVLsOL8IgVBpmZEGDeJnhZDl2jetO2kc7KSou74DW3i5PglOOyOkWbDylX3O8fX1FwRPKBlTQtMXq7FdoxpHvh5TOiaU3Q0GNGFRyEga3wsGpEjiMKWUngQPnVsRQoo4Jg-CkygraBrn0eDO8_3u93Qjqk602tRgSpBLa2otwcxdazvZ6g1C01VrUwu7BaUdCocwnFx-fDcCUSuwqDqJCnCF8hBSWnEslihsC6XQVWe95Wxmp7NRHyGXwi4QfPdaHi9uLDpp9VzXi5dw7kDZbgHtEq1otiBNLY1Vom7hp26XUB88ooJFpxVWukYHwjkjtWh9IweNOPZ1CNc1MBIqsfV7Qq21c37Xvdnv_sC3T-gabcfwwU8SKC1geClbM0cL_VxHQFmy3_2iMfn-KLhfisrh4-v1NPg6m36ZnIUXl-_PJ28vQhlT1oY5S5I4E7LIaJHQDJXICUklS2Se5ejjSJaVeZ6opFRxrHJVFEjSXJSiKGJBEnYaDI-5jTU_OnQt9x1LrCpRo-kcp3mckihjeS99dku6Mp31k-lVKUtSlqbUq6KjSlrjnMWSN1av_W9ySnhPEl_xniTev5hTyj1J3vT0Orqb92c3lht0vODVUYB-FhuNljupsfYkaOtB4Mro_-e_vmWX_iM9DtUVbtH9ewd3ESf8c89yjzJNGWEkJ-wvO83yjQ</recordid><startdate>20170201</startdate><enddate>20170201</enddate><creator>Richardson, Amy</creator><creator>Tolley, Elizabeth</creator><creator>Hartmann, Jonathan</creator><creator>Reedus, Jasmine</creator><creator>Bowlin, Brandi</creator><creator>Finch, Christopher</creator><creator>Sands, Christopher W</creator><creator>Self, Timothy</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>ASE</scope><scope>FPQ</scope><scope>H94</scope><scope>K6X</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20170201</creationdate><title>“Evaluation of chronic obstructive pulmonary disease (COPD) and reduced ejection fraction heart failure (HFrEF) discharge medication prescribing: Is drug therapy concordant with national guidelines associated with a reduction in 30-day readmissions?” [Respir. Med. 119 (October 2016) 135–140]</title><author>Richardson, Amy ; Tolley, Elizabeth ; Hartmann, Jonathan ; Reedus, Jasmine ; Bowlin, Brandi ; Finch, Christopher ; Sands, Christopher W ; Self, Timothy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c413t-835547ac9719517eda8006c35c878e135077f885d5fd44d8d99e068afa994a053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Pulmonary/Respiratory</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Richardson, Amy</creatorcontrib><creatorcontrib>Tolley, Elizabeth</creatorcontrib><creatorcontrib>Hartmann, Jonathan</creatorcontrib><creatorcontrib>Reedus, Jasmine</creatorcontrib><creatorcontrib>Bowlin, Brandi</creatorcontrib><creatorcontrib>Finch, Christopher</creatorcontrib><creatorcontrib>Sands, Christopher W</creatorcontrib><creatorcontrib>Self, Timothy</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Respiratory medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Richardson, Amy</au><au>Tolley, Elizabeth</au><au>Hartmann, Jonathan</au><au>Reedus, Jasmine</au><au>Bowlin, Brandi</au><au>Finch, Christopher</au><au>Sands, Christopher W</au><au>Self, Timothy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>“Evaluation of chronic obstructive pulmonary disease (COPD) and reduced ejection fraction heart failure (HFrEF) discharge medication prescribing: Is drug therapy concordant with national guidelines associated with a reduction in 30-day readmissions?” [Respir. Med. 119 (October 2016) 135–140]</atitle><jtitle>Respiratory medicine</jtitle><addtitle>Respir Med</addtitle><date>2017-02-01</date><risdate>2017</risdate><volume>123</volume><spage>150</spage><epage>150</epage><pages>150-150</pages><issn>0954-6111</issn><eissn>1532-3064</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>27916482</pmid><doi>10.1016/j.rmed.2016.11.013</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0954-6111
ispartof Respiratory medicine, 2017-02, Vol.123, p.150-150
issn 0954-6111
1532-3064
language eng
recordid cdi_proquest_miscellaneous_1846027385
source Elsevier ScienceDirect Journals Complete; EZB-FREE-00999 freely available EZB journals
subjects Pulmonary/Respiratory
title “Evaluation of chronic obstructive pulmonary disease (COPD) and reduced ejection fraction heart failure (HFrEF) discharge medication prescribing: Is drug therapy concordant with national guidelines associated with a reduction in 30-day readmissions?” [Respir. Med. 119 (October 2016) 135–140]
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T11%3A01%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%E2%80%9CEvaluation%20of%20chronic%20obstructive%20pulmonary%20disease%20(COPD)%20and%20reduced%20ejection%20fraction%20heart%20failure%20(HFrEF)%20discharge%20medication%20prescribing:%20Is%20drug%20therapy%20concordant%20with%20national%20guidelines%20associated%20with%20a%20reduction%20in%2030-day%20readmissions?%E2%80%9D%20%5BRespir.%20Med.%20119%20(October%202016)%20135%E2%80%93140%5D&rft.jtitle=Respiratory%20medicine&rft.au=Richardson,%20Amy&rft.date=2017-02-01&rft.volume=123&rft.spage=150&rft.epage=150&rft.pages=150-150&rft.issn=0954-6111&rft.eissn=1532-3064&rft_id=info:doi/10.1016/j.rmed.2016.11.013&rft_dat=%3Cproquest_cross%3E4311598401%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1863563661&rft_id=info:pmid/27916482&rft_els_id=1_s2_0_S0954611116303080&rfr_iscdi=true